|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Structure, Biology and clinical Utility 显示文摘 | Krause DS Fackler MJ Civin CI | 1996 | Blood1996，87，： | 1 |
| 2 | CD34: Structure,Biology, and Clinical Utility显示文摘 | Krause DS Fackler MJ Civin CI | 1996 | Blood1996，87，1： | 1 |
| 3 | Quantitative multiplex raethylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer显示文摘 | Fackler MJ McVeigh M Mehrotra J | 2004 | Cancer Res2004，64，13： | 1 |
| 4 | Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast duetal fluid显示文摘 | Fackler MJ Malone K Zbeng Z | 2006 | Clin Cancer Res2006，12，1： | 1 |
| 5 | CD34: structure, biology and clinical utility显示文摘 | Krause DS Fackler MJ Civin CI | 1996 | Blood1996，87，： | 1 |
| 6 | CD34: Structure,biology and clinical utility显示文摘 | KRAUSE DS FACKLER MJ Civin CL | 1996 | Blood1996，87，1： | 1 |
| 7 | Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer显示文摘 | Fackler MJ Lopez Bujanda Z Umbricht C | 2014 | Cancer Res2014，74，： | 1 |
| 8 | CD34 : Structure, biology and clinical utility 显示文摘 | Krause DS Fackler MJ Civin CL | 1996 | Blood1996，87，1： | 1 |
| 9 | CD34:Structure,biology and clinical utility显示文摘 | Krause DS Fackler MJ Civin CL | 1996 | Blood1996，87，1： | 1 |
| 10 | DNA methylation of RASSF1A,HIN-1,RAR-beta,Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma显示文摘 | Fackler MJ McVeigh M Evron E | 2003 | Int J Cancer2003，107，6： | 1 |
| 11 | Heterogeneityof breast cancer metastases: comparison of therapeutictarget expression and promoter methylation between pri-mary tumors and their multifocal metastases显示文摘 | Wu JM Fackler MJ Halushka MK | 2008 | Clin CancerRes2008，14，7： | 1 |
| 12 | Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer显示文摘 | Suijkerhuijk KP Fackler MJ Sukumar S | 2008 | Ann Oncol2008，19，11： | 1 |
| 13 | CD34: structure, biolo- gy, and clinical utility 显示文摘 | Krause DS Fackler MJ Civin CI | 1996 | Blood1996，87，1： | 1 |
| 14 | Human CD34+ cell preparations contain over 100-fold greater NOD/SCID mouse engrafting capacity than do CD34-cell preparations 显示文摘 | Gao Z Fackler MJ Leung W | 2001 | Exp Hematol2001，29，7： | 1 |
| 15 | Quantitative multiplex methylation specific PCR assay for the detection of promoter hypermethylation in multiple gene in breast cancer显示文摘 | Fackler MJ McVeigh M Mehrotra J | 2004 | Cancer Res2004，64，13： | 1 |
| 16 | DNA methylation of RASSF1A,HIN-1,RAR-beta,Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma显示文摘 | Fackler MJ McVeigh M Evron E | 2003 | Int J Cancer2003，107，6： | 1 |
| 17 | Human CD34+cell prepa-rations contain over 100-fold greater NOD/SCID mouse engraftingcapacity than do CD34-cell preparations显示文摘 | Gao Z Fackler MJ Leung W | 2001 | Exp Hematol2001，29，： | 1 |
| 18 | CD34 : structure, biology and clinical utility显示文摘 | Krause DS Fackler MJ Civin CI | 1996 | Blood1996，87，： | 1 |
| 19 | 显示文摘 | Krause DS Fackler MJ | 1996 | Blood1996，87，1： | 1 |
| 20 | Characterization of murineCD34, a marker for hematopoietic progenitor and stem cells 显示文摘 | Krause DS Ito T Fackler MJ | 1994 | Blood1994，84，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员